In 2013 Markus Möllmann-Bohle was fitted with an electronic implant to treat debilitating cluster headaches. Six years later the manufacturer ceased trading and Markus was left to maintain his device by himself. In this film, we hear his story.

The multi-billion dollar neurotechnology market is predicted to expand by around 75% in the coming years. But as commercial investment grows, so too do commercial failures, abandoning thousands of people, like Markus, who have come to depend on the now unsupported devices.

Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.